Second and third-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumour activity

GV Suárez-Moreno, D Hernández-Romero… - Coordination Chemistry …, 2022 - Elsevier
The application of metal compounds in the medical field dates back to the XVI century with
some isolated reports about the therapeutic importance of metals and their compounds in …

Coordination compounds in cancer: Past, present and perspectives

F Trudu, F Amato, P Vaňhara, T Pivetta… - Journal of applied …, 2015 - Elsevier
Metal-based coordination compounds have been used throughout the history of human
medicine to treat various diseases, including cancer. Since the discovery of cisplatin in …

The therapeutic potential of iron-targeting gallium compounds in human disease: From basic research to clinical application

CR Chitambar - Pharmacological research, 2017 - Elsevier
Gallium, group IIIa metal, shares certain chemical characteristics with iron which enable it to
function as an iron mimetic that can disrupt iron-dependent tumor cell growth. Gallium may …

[PDF][PDF] The molecular mechanisms of calpains action on skeletal muscle atrophy.

J Huang, ZHU Xiaoping - Physiological Research, 2016 - biomed.cas.cz
Skeletal muscle atrophy is associated with a loss of muscle protein which may result from
both increased proteolysis and decreased protein synthesis. Investigations on cell signaling …

Alkynyl gold (I) phosphane complexes: Evaluation of structure–activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in …

V Andermark, K Göke, M Kokoschka… - Journal of Inorganic …, 2016 - Elsevier
Gold alkynyl complexes with phosphane ligands of the type (alkynyl) Au (I)(phosphane)
represent a group of bioorganometallics, which has only recently been evaluated …

Gallium complexes as anticancer drugs

CR Chitambar - Met. Ions Life Sci, 2018 - degruyter.com
7. SUMMARY AND OUTLOOK 296 ACKNOWLEDGMENTS 297 ABBREVIATIONS 297
REFERENCES 297 Abstract: Clinical trials have shown gallium nitrate, a group 13 (formerly …

[HTML][HTML] The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of …

NL Wilke, LO Abodo, C Frias, J Frias, J Baas… - Biomedicine & …, 2022 - Elsevier
Abstract Tris-(8-quinolinolato) gallium (III)(KP46, AP-002) is an orally administered
investigational anticancer and bone-protective drug currently being evaluated in patients …

Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs

E Schreiber-Brynzak, E Klapproth, C Unger… - Investigational new …, 2015 - Springer
Background Hypoxic and necrotic regions that accrue within solid tumors in vivo are known
to be associated with metastasis formation, radio-and chemotherapy resistance, and drug …

[HTML][HTML] Inhibiting calpain 1 and 2 in cyclin G associated kinase–knockout mice mitigates podocyte injury

X Tian, K Inoue, Y Zhang, Y Wang, CJ Sperati… - JCI insight, 2020 - ncbi.nlm.nih.gov
Evidence for reduced expression of cyclin G associated kinase (GAK) in glomeruli of
patients with chronic kidney disease was observed in the Nephroseq human database, and …

Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells-synergism with autophagy inhibition

B Kubista, T Schoefl, L Mayr… - Journal of Experimental …, 2017 - Springer
Background Osteosarcoma is the most frequent primary malignant bone tumor. Although
survival has distinctly increased due to neoadjuvant chemotherapy in the past, patients with …